- Mithra realized its best selling month in June 2016
- Mithra remains leader in contraception on the Belgian market (in terms of cycles)
- Mithra becomes N°2 in terms of value ahead of Organon (MSD)
- The trend in the market confirms Mithra’s Estetrol-based developments
Liège, Belgium 26 July 2016 – In terms of cycles, Mithra announces that it recorded a 2.8% market share growth compared to June 2015. This represents a significant growth given the 1% decrease recorded on the Belgian contraception market over the same period.